Bio-Techne TECH Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's total cost of revenue?
- Bio-Techne (TECH) reported total cost of revenue of $103.13M in Q1 2026.
- How has Bio-Techne's total cost of revenue changed year-over-year?
- Bio-Techne's total cost of revenue increased by 1.5% year-over-year, from $101.63M to $103.13M.
- What is the long-term trend for Bio-Techne's total cost of revenue?
- Over 3 years (2022 to 2025), Bio-Techne's total cost of revenue has grown at a 7.1% compound annual growth rate (CAGR), from $349.1M to $429.36M.
- What does total cost of revenue mean?
- The direct costs incurred to produce the products or services sold by the company.
- How do you interpret total cost of revenue?
- An increase relative to revenue suggests margin compression, while a decrease suggests improved operational efficiency or lower input costs.
- How does total cost of revenue compare across companies?
- Varies by industry; life sciences manufacturers typically maintain consistent cost structures based on supply chain efficiency.